Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
A 63-year-old man with Type 1 diabetes received a transplant of insulin-producing cells with the aid of a device that eliminated use of immune-blocking drugs, a potential breakthrough that may lead to safer and more effective procedures to revive weakened organs.
The cells, which survived for 10 months, showed signs of insulin production, according to a study released today by the Proceedings of the National Academy of Sciences. The new approach may lead to diabetes therapies, as well as open the possibility of other types of tissue transplants where side effects of immune suppression may outweigh the benefits.
http://www.bloomberg.com/news/2013-10-28/transplant-without-immune-drugs-may-work-study-finds.html
The cells, which survived for 10 months, showed signs of insulin production, according to a study released today by the Proceedings of the National Academy of Sciences. The new approach may lead to diabetes therapies, as well as open the possibility of other types of tissue transplants where side effects of immune suppression may outweigh the benefits.
http://www.bloomberg.com/news/2013-10-28/transplant-without-immune-drugs-may-work-study-finds.html